Therefore, AMH mutations in PCOS are suggested to result in decreased AMH-mediated inhibition of CYP17 expression and androgen biosynthesis, leading to syndrome-specific hyperandrogenism. The gene discussed is AMH; the disease is polycystic ovary syndrome.